{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Drug+Use+Disorders&page=37", "query": { "condition": "Drug Use Disorders", "page": 37 }, "page_size": 10 }, "pagination": { "page": 37, "page_size": 10, "total_count": 1123, "total_pages": 113, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Drug+Use+Disorders&page=38&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Drug+Use+Disorders&page=36&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T14:58:06.278Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03944447", "title": "Outcomes Mandate National Integration With Cannabis as Medicine", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Pain", "Chronic Pain Syndrome", "Chronic Pain Due to Injury", "Chronic Pain Due to Trauma", "Fibromyalgia", "Seizures", "Hepatitis C", "Cancer", "Crohn Disease", "HIV/AIDS", "Multiple Sclerosis", "Traumatic Brain Injury", "Sickle Cell Disease", "Post Traumatic Stress Disorder", "Tourette Syndrome", "Ulcerative Colitis", "Glaucoma", "Epilepsy", "Inflammatory Bowel Diseases", "Parkinson Disease", "Amyotrophic Lateral Sclerosis", "Chronic Traumatic Encephalopathy", "Anxiety", "Depression", "Insomnia", "Autism", "Opioid-use Disorder", "Bipolar Disorder", "Covid19", "SARS-CoV Infection", "COVID-19", "Corona Virus Infection", "Coronavirus" ], "interventions": [ { "name": "Cannabis, Medical", "type": "DRUG" }, { "name": "RYAH-Medtech Inhaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "OMNI Medical Services, LLC", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 200000, "start_date": "2018-12-01", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2022-06-02", "last_synced_at": "2026-10-24T14:58:06.278Z", "location_count": 17, "location_summary": "Boca Raton, Florida • Bradenton, Florida • Fort Lauderdale, Florida + 13 more", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03944447" }, { "nct_id": "NCT01236248", "title": "Drug Abuse Prevention Among Girls Through a Mother-Daughter Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Substance Use" ], "interventions": [ { "name": "Prevention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "13 Years", "sex": "FEMALE", "summary": "11 Years to 13 Years · Female only" }, "enrollment_count": 916, "start_date": "2004-12", "completion_date": "2012-10-04", "has_results": false, "last_update_posted_date": "2017-07-18", "last_synced_at": "2026-10-24T14:58:06.278Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01236248" }, { "nct_id": "NCT05776316", "title": "Harm Reduction Services", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Drug Use", "Substance Abuse", "Mental Illness" ], "interventions": [ { "name": "Integrated Harm Reduction Intervention (IHRI)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2024-11-25", "completion_date": "2028-03-28", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-10-24T14:58:06.278Z", "location_count": 3, "location_summary": "New Haven, Connecticut • New York, New York • Orangeburg, New York", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "New York", "state": "New York" }, { "city": "Orangeburg", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05776316" }, { "nct_id": "NCT07711795", "title": "Mindfulness Texting for Medication Adherence and Chronic Pain Management", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Opioid Use Disorder (OUD)", "Chronic Pain" ], "interventions": [ { "name": "Mindfulness text messages", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2025-04-23", "completion_date": "2027-10", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-10-24T14:58:06.278Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT07711795" }, { "nct_id": "NCT01710072", "title": "Aspirin Attenuates Inflammation in Human Cerebral Aneurysms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "The Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral Aneurysm" ], "interventions": [ { "name": "aspirin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Iowa", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 11, "start_date": "2011-08", "completion_date": "2014-08", "has_results": false, "last_update_posted_date": "2015-05-29", "last_synced_at": "2026-10-24T14:58:06.278Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01710072" }, { "nct_id": "NCT05733442", "title": "Counseling for Harm Reduction and Retention in Medication-assisted Treatment - Cherokee Nation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Opioid Use Disorder" ], "interventions": [ { "name": "Treatment as usual (TAU)", "type": "OTHER" }, { "name": "CHaRRM-CN", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Washington State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 136, "start_date": "2023-01-17", "completion_date": "2026-07-31", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-10-24T14:58:06.278Z", "location_count": 2, "location_summary": "Tahlequah, Oklahoma • Seattle, Washington", "locations": [ { "city": "Tahlequah", "state": "Oklahoma" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05733442" }, { "nct_id": "NCT03318666", "title": "Supporting Our Valued Adolescents Pilot Randomized Controlled Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression", "Anxiety" ], "interventions": [ { "name": "Supporting Our Valued Adolescents (SOVA)", "type": "BEHAVIORAL" }, { "name": "Enhanced Usual Care", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "19 Years", "sex": "ALL", "summary": "12 Years to 19 Years" }, "enrollment_count": 38, "start_date": "2018-04-17", "completion_date": "2020-04-06", "has_results": false, "last_update_posted_date": "2021-10-26", "last_synced_at": "2026-10-24T14:58:06.278Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03318666" }, { "nct_id": "NCT00247572", "title": "Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Attention Deficit Disorder With Hyperactivity", "Amphetamine-Related Disorders", "Substance-Related Disorders" ], "interventions": [ { "name": "NRP104", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New River Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2005-09", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2007-11-05", "last_synced_at": "2026-10-24T14:58:06.278Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00247572" }, { "nct_id": "NCT03694327", "title": "Innovative Digital Therapeutic for Smoking Cessation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking Cessation", "Nicotine Addiction", "Drug Addiction", "Drug Dependence", "Tobacco Dependence", "Tobacco Use Disorder", "Substance Use Disorder", "Tobacco Smoking" ], "interventions": [ { "name": "CT-101-M", "type": "DEVICE" }, { "name": "QuitGuide", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "My Digital Study", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 158, "start_date": "2018-10-24", "completion_date": "2019-03-14", "has_results": true, "last_update_posted_date": "2022-06-06", "last_synced_at": "2026-10-24T14:58:06.278Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03694327" }, { "nct_id": "NCT03605966", "title": "Developing a Method to Objectively Measure Opioid Analgesia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Analgesics, Antipyretics and Anti-Inflammatory Drugs Causing Adverse Effects in Therapeutic Use" ], "interventions": [], "intervention_types": [], "sponsor": "Julia Finkel", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "7 Years to 21 Years" }, "enrollment_count": 40, "start_date": "2018-07-01", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-04-06", "last_synced_at": "2026-10-24T14:58:06.278Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03605966" } ] }